Efficacy and safety outcomes with remdesivir in COVID-19 patients: A meta-analysis

Table 2 Risk of bias assessment as per the Revised Cochrane risk of bias tool for randomized trials

Domain No.	Risk of bias domains	Beigel et al[14]	WHO Solidarity Trial Consortium et al[15]	Spinner et al[20]	Wang et al[21]
1	Risk of bias arising from the randomization process	Low	Low	Low	Low
2a	Risk of bias due to deviations from the intended interventions (effect of assignment to intervention)	Low	Low	Some concern	Low
2b	Risk of bias due to deviations from the intended interventions (effect of adhering to intervention)	Low	Low	Low	Low
3	Missing outcome data	Low	Low	Low	Low
4	Risk of bias in measurement of the outcome	Low	Low	Low	Low
5	Risk of bias in selection of the reported result	Low	Low	Low	Low
--	Overall risk of bias assessment	Low	Low	Some concerns	Low

WHO: World Health Organization.